FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis

Lupus glomerulonephritis is initiated by deposition of IgG-containing immune complexes in renal glomeruli. FcR engagement by immune complexes (IC) is crucial to disease development as uncoupling this pathway in FcR gamma(-/-) abrogates inflammatory responses in (NZB x NZW)F-1 mice. To define the roles of FcR-bearing hemopoietic cells and of kidney resident mesangial cells in pathogenesis, (NZB X NZW)F-1 bone marrow chimeras were generated. Nephritis developed in (NZB x NZW)F-1 mice expressing activating FcRs in hemopoietic cells. Conversely, recipients of FcR gamma(-/-) bone marrow were protected from disease development despite persistent expression of FcR gamma in mesangial cell populations. Thus, activating FcRs on circulating hemopoietic cells, rather than on mesangial cells, are required for IC-mediated pathogenesis in (NZB x NZW)F-1. Transgenic FcR gamma(-/-) mice expressing FcR gamma limited to the CD11b(+) monocyte/macrophage compartment developed glomerulonephritis in the anti-glomerular basement disease model, whereas nontransgenic FcR gamma(-/-) mice were completely protected. Thus, direct activation of circulating FcR-bearing myeloid cells, including monocytes/macrophages, by glomerular IC deposits is sufficient to initiate inflammatory responses.